Meetings: National Institute of Allergy and Infectious Diseases,

[Federal Register: April 19, 1999 (Volume 64, Number 74)]

[Notices]

[Page 19186]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr19ap99-72]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel HIV Vaccine Production: Part C FDA Submissions.

Date: April 26, 1999.

Time: 12:00 PM to 3:00 PM.

Agenda: To review and evaluate contract proposals.

Place: Solar Building, Room 4C07, 6003 Executive Boulevard, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Dianne E. Tingley, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID, NIH, Solar Building, Room 4C07, 6003 Executive Boulevard MSC 7610, Bethesda, MD 20892-7610, 301/496-0818.

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: April 13, 1999. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy, NIH.

[FR Doc. 99-9669Filed4-16-99; 8:45 am]

BILLING CODE 4140-01-M